Published in Lancet on April 22, 2000
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol (2011) 1.86
Distinct neuropsychological characteristics in Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2002) 1.48
Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-- Jakob disease: implications for human health. Proc Natl Acad Sci U S A (2001) 1.46
The evaluation of rapidly progressive dementia. Neurologist (2011) 1.30
Neuroimaging findings in human prion disease. J Neurol Neurosurg Psychiatry (2006) 1.21
Variant Creutzfeldt-Jakob disease: a summary of current scientific knowledge in relation to public health. CMAJ (2001) 1.18
Assessment of paramedian thalamic infarcts: MR imaging, clinical features and prognosis. Eur Radiol (2004) 1.08
How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II. J Neural Transm (Vienna) (2006) 1.07
Radiological assessment of Creutzfeldt-Jakob disease. Eur Radiol (2006) 1.02
Susceptibility of domestic cats to chronic wasting disease. J Virol (2012) 0.96
Presenile dementia syndromes: an update on taxonomy and diagnosis. J Neurol Neurosurg Psychiatry (2002) 0.95
Variant CJD. 18 years of research and surveillance. Prion (2014) 0.93
Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol (2013) 0.92
Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopy. Neuroradiology (2006) 0.92
Bilateral thalamic infarcts due to occlusion of the Artery of Percheron and discussion of the differential diagnosis of bilateral thalamic lesions. J Radiol Case Rep (2013) 0.90
Neuroimaging in dementia. Neurotherapeutics (2011) 0.89
MRI and the second French case of vCJD. Lancet (2000) 0.88
Unusual cause of dementia in an immunocompetent host: toxoplasmic encephalitis. Neurol Sci (2009) 0.87
Short TE quantitative proton magnetic resonance spectroscopy in variant Creutzfeldt-Jakob disease. Eur Radiol (2006) 0.86
MR imaging findings in alcoholic and nonalcoholic acute Wernicke's encephalopathy: a review. Biomed Res Int (2014) 0.83
Unusual acute encephalitis involving the thalamus: imaging features. Korean J Radiol (2001) 0.83
Extensive cortical damage in a case of Creutzfeldt-Jacob disease: clinicoradiological correlations. Neuroradiology (2003) 0.82
Carcinomatous meningitis: Yet another cause for rapidly progressive dementia and triphasic waves in electroencephalograph! J Neurosci Rural Pract (2012) 0.82
Diffusion-weighted MR imaging in biopsy-proven Creutzfeldt-Jakob disease. Korean J Radiol (2001) 0.80
Rapid echoplanar diffusion imaging in a case of variant Creutzfeldt-Jakob disease; where speed is of the essence. Neuroradiology (2003) 0.80
The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease. J Neurol Neurosurg Psychiatry (2005) 0.79
Heidenhain variant of Creutzfeldt-Jakob disease: An autopsy study from India. Ann Indian Acad Neurol (2009) 0.79
Neuroimaging in dementia. Semin Neurol (2008) 0.78
Pulvinar sign in acute disseminated encephalomyelitis. Ann Indian Acad Neurol (2014) 0.78
Diffusion-weighted imaging: As the first diagnostic clue to Creutzfeldt Jacob disease. J Neurosci Rural Pract (2012) 0.75
Neuroanatomical correlates of prion disease progression - a 3T longitudinal voxel-based morphometry study. Neuroimage Clin (2016) 0.75
Neuroimaging in human prion disease: Searching in the mist. World J Radiol (2009) 0.75
Neurological disorders presenting mainly in adolescence. Arch Dis Child (2007) 0.75
New-variant Creutzfeldt-Jacob disease. Br J Gen Pract (2000) 0.75
Pulvinar sign in a case of anti-HU paraneoplastic encephalitis. Neuroradiol J (2016) 0.75
Recent developments in the pathogenesis, diagnosis, and therapy of prion diseases. Dialogues Clin Neurosci (2001) 0.75
Pulvinar sign on MRI images in variant Creutzfeldt-Jakob disease. Lancet (2000) 0.75
Comprehensive and Methodical: Diagnostic and Management Approaches to Rapidly Progressive Dementia. Curr Treat Options Neurol (2017) 0.75
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73
Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. Health Technol Assess (2007) 6.55
Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA (1998) 6.43
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet (2004) 4.85
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol (2000) 3.99
"Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet (1992) 3.74
Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet (1999) 3.61
A community-based programme to provide prompt and adequate treatment of presumptive malaria in children. Trans R Soc Trop Med Hyg (1998) 3.42
Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet (1999) 3.39
Cerebral perfusion deficits in dysbaric illness. Lancet (1989) 3.31
Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol (2006) 3.29
Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology (2000) 3.23
Ratings of profile attractiveness after functional appliance treatment. Am J Orthod Dentofacial Orthop (2000) 3.20
Alternatives to randomisation in the evaluation of public health interventions: design challenges and solutions. J Epidemiol Community Health (2009) 3.15
Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet (1998) 3.08
Txt2stop: a pilot randomised controlled trial of mobile phone-based smoking cessation support. Tob Control (2009) 3.05
Predicting the CJD epidemic in humans. Nature (1997) 3.04
Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology (2000) 3.03
Evaluation of investigations to diagnose the cause of dizziness in elderly people: a community based controlled study. BMJ (1996) 3.03
Epidemic of fatal encephalopathy in preschool children in Burkina Faso and consumption of unripe ackee (Blighia sapida) fruit. Lancet (1999) 2.98
Creutzfeldt-Jakob disease and blood transfusion. Lancet (1993) 2.97
Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80
A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features. J Neurol Neurosurg Psychiatry (1984) 2.68
Cerebral angiographic risk in mild cerebrovascular disease. Stroke (1990) 2.65
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg Infect Dis (2001) 2.62
Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet (2000) 2.59
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain (2006) 2.54
The importance of list size and consultation length as factors in general practice. J R Coll Gen Pract (1987) 2.49
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Evidence of behaviour change following a hygiene promotion programme in Burkina Faso. Bull World Health Organ (2001) 2.47
Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. Br J Ophthalmol (1994) 2.47
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol (2000) 2.42
Extent of misclassification of death from Creutzfeldt-Jakob disease in England 1979-96: retrospective examination of clinical records. BMJ (2000) 2.32
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry (2010) 2.29
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2006) 2.19
Structured observations of hygiene behaviours in Burkina Faso: validity, variability, and utility. Bull World Health Organ (1993) 2.19
In vitro evaluation of tobramycin, a new aminoglycoside antibiotic. Antimicrob Agents Chemother (1972) 2.18
HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat Med (1997) 2.15
MICROBIOME. A unified initiative to harness Earth's microbiomes. Science (2015) 2.15
Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (1982) 2.15
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15
Neck soft tissue and fat distribution: comparison between normal men and women by magnetic resonance imaging. Thorax (1999) 2.12
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord (2000) 2.10
Radiation dose to the lens from computed tomography scanning in a neuroradiology department. Br J Radiol (1995) 2.07
The Functional Independence Measure: a comparative validity and reliability study. Disabil Rehabil (1995) 2.04
Deaths from variant Creutzfeldt-Jakob disease. Lancet (1999) 2.04
Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders. Haemophilia (2010) 2.03
Cost-effective carotid endarterectomy. Br J Surg (2000) 2.02
High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol (1997) 2.00
Measuring hygiene practices: a comparison of questionnaires with direct observations in rural Zaïre. Trop Med Int Health (1997) 1.99
CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients? J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.99
Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000. Lancet (2001) 1.97
Neutral-lipid storage disease: a new disorder of lipid metabolism. Br Med J (1975) 1.97
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain (2004) 1.96
Potties, pits and pipes: explaining hygiene behaviour in Burkina Faso. Soc Sci Med (1995) 1.95
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology (2005) 1.88
Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry (1988) 1.87
Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet (2001) 1.84
Itch: a HECT-type E3 ligase regulating immunity, skin and cancer. Cell Death Differ (2008) 1.77
Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang (2006) 1.76
Development of neurological problems after lumbar puncture. Br Med J (Clin Res Ed) (1988) 1.75
Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial. Eur Heart J (2004) 1.74
Acyl-homoserine lactone production is more common among plant-associated Pseudomonas spp. than among soilborne Pseudomonas spp. Appl Environ Microbiol (2001) 1.74
The role of non-biting flies in the epidemiology of human infectious diseases. Microbes Infect (2001) 1.74
New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet (1997) 1.70
Reproducibility of metabolite peak areas in 1H MRS of brain. Magn Reson Imaging (1996) 1.70
Amount of research interest in rare and common neurological conditions: bibliometric study. BMJ (2001) 1.68
The arginine repressor is essential for plasmid-stabilizing site-specific recombination at the ColE1 cer locus. EMBO J (1988) 1.67
Diagnosis, personality and the long-term outcome of depression. Br J Psychiatry (1990) 1.66
Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol (1996) 1.66
Outcome, observer reliability, and patient preferences if CTA, MRA, or Doppler ultrasound were used, individually or together, instead of digital subtraction angiography before carotid endarterectomy. J Neurol Neurosurg Psychiatry (2002) 1.64
A mutation in the second nucleotide binding fold of the cystic fibrosis gene. Am J Hum Genet (1991) 1.62
MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology (2009) 1.61
Neck and total body fat deposition in nonobese and obese patients with sleep apnea compared with that in control subjects. Am J Respir Crit Care Med (1998) 1.61
Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet (1998) 1.60
New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet (1997) 1.55
Renal venous thrombosis with calcification and preservation of renal function. Pediatr Radiol (2001) 1.53
Survey of attitudes to testing for human immunodeficiency virus infection in antenatal clinics in West Glamorgan. Br J Obstet Gynaecol (1989) 1.51
Tissue and organ donation for research in forensic pathology: the MRC Sudden Death Brain and Tissue Bank. J Pathol (2007) 1.51